series-c-plus
Stage
1
Investors
About
Univercells develops and manufactures intensified bioprocessing technologies, including scalable bioreactors, for viral vector and vaccine production to support gene and cell therapy manufacturing.
Explore Univercells SA's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.